BlackRock’s Fink Sold $20 Million of Stock After Share Gains
(Bloomberg) -- BlackRock Inc. Chief Executive Officer Larry Fink sold $20 million of stock in the world's largest asset manager, following several divestitures last year.
Fink disposed of 27,400 shares at an average price of $728.77 on Feb. 2, according to a regulatory filing. The transactions reduced his direct ownership of the company shares by 3.5%.
The billionaire still owns $560 million of BlackRock stock, according to data compiled by Bloomberg. The company disappointed some investors in January when it said that margin guidance for this year would be the same as last year, adding that it plans to repurpose lower travel expenses into funding for technology and market data investments to support sustainability.
Fink also sold about $2 million of BlackRock shares last month, a separate filing shows. He offloaded at least $74.4 million of shares by late July last year, following the footsteps of other corporate insiders. Almost 1,000 executives and officers unloaded stock in their own companies that month.
BlackRock's Chief Operating Officer Rob Goldstein traded in about $2.8 million of shares of the company this month, according to filings. Executives including Mark Wiedman and Mark McCombe made similar moves in recent days, filings show.
The company has gained 3% in the past month, with insiders holding 1.29% of total shares, according to data compiled by Bloomberg. A representative for BlackRock didn't immediately respond to an emailed query.
©2021 Bloomberg L.P.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.